The main weapon in the treatment of hypertension represents, as is natural, mineralocorticoid receptor antagonists, generally associated with other classes of antihypertensive agents (ACE inhibitors, angiotensin receptor blockers, Ca blockers, α-or β- blockers). This evidence concerns the gene NR3C2 and hypertensive disorder.